AVLSA
FSTX
Atlas Venture Life Science Advisors’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-599,524
| Closed | -$3.79M | – | 17 |
|
|
2022
Q4 | $3.79M | Hold |
599,524
| – | – | 0.46% | 13 |
|
|
2022
Q3 | $3.07M | Hold |
599,524
| – | – | 0.34% | 14 |
|
|
2022
Q2 | $3.75M | Hold |
599,524
| – | – | 0.63% | 14 |
|
|
2022
Q1 | $2.13M | Hold |
599,524
| – | – | 0.27% | 15 |
|
|
2021
Q4 | $3.01M | Buy |
+599,524
| New | +$3.01M | 0.28% | 14 |
|